Clinical efficacy of ruxolitinib and chemotherapy in a child with Philadelphia chromosome-like acute lymphoblastic leukemia with GOLGA5-JAK2 fusion and induction failure

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2018-09, Vol.103 (9), p.e427-e431
Hauptverfasser:	Ding, Yang Y, Stern, Julie W, Jubelirer, Tracey F, Wertheim, Gerald B, Lin, Fumin, Chang, Fengqi, Gu, Zhaohui, Mullighan, Charles G, Li, Yong, Harvey, Richard C, Chen, I-Ming, Willman, Cheryl L, Hunger, Stephen P, Li, Marilyn M, Tasian, Sarah K
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Child Golgi Matrix Proteins - genetics Humans In Situ Hybridization, Fluorescence Janus Kinase 2 - genetics Karyotyping Male Molecular Targeted Therapy Oncogene Proteins, Fusion - genetics Online Only Philadelphia Chromosome Precursor Cell Lymphoblastic Leukemia-Lymphoma - diagnosis Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Pyrazoles - administration & dosage Pyrazoles - adverse effects Pyrazoles - therapeutic use Remission Induction Retreatment Treatment Failure Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!